IP Library Granted Patent US 9,403,888
Granted Patent B2
US 9,403,888 · App. 14/363,793 · Granted Aug 2, 2016

Compositions and methods for purifying Bax

Inventor: Annette Khaled (Orlando, FL)
Assignee: University of Central Florida Research Foundation, Inc.
C07K14/4747C07K2319/036
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,403,888
App. No.
14/363,793
Granted
Aug 2, 2016
Kind
B2
Abstract

Disclosed are compositions and methods for purifying a Bax protein. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claims (10)

1. A method of purifying a Bax protein, comprising: modifying a nucleic acid encoding a Bax protein to further encode an HMM peptide; expressing the modified nucleic acid in a host cell; and culturing the host cell in a medium; harvesting the medium; and purifying the Bax protein from the harvested medium, wherein the HMM peptide has 99%, 98%, 97%, 96%, 95%, 94%, 93% 92%, 91%, or 90% sequence identity to MWWRLWWLLLLLLLLWPMVWA (SEQ ID NO:2).

2. The method of claim 1 , further comprising concentrating the harvested medium.

3. The method of claim 1 , further comprising assessing Bax protein content, Bax protein concentration, Bax protein conformation integrity, or Bax protein activity.

4. The method of claim 1 , wherein the host cell is a mammalian cell.

5. The method of claim 1 , wherein the HMM peptide is MWWRLWWLLLLLLLLWPMVWA (SEQ ID NO:2).

6. The method of claim 1 , wherein the Bax protein is encoded by a nucleotide sequence of SEQ ID NO:5.

7. The method of claim 1 , wherein the modified nucleic acid comprises the nucleotide sequence of SEQ ID NO:3.

8. The method of claim 1 , wherein the purified Bax protein is wild-type Bax.

9. The method of claim 1 , wherein the purified Bax protein is a mutant Bax protein.

10. The method of claim 9 , wherein the purified mutant Bax protein comprises a C-terminal deletion.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 27, 2015
From: UNIVERSITY OF CENTRAL FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035111/0613 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2014
From: KHALED, ANNETTE
To: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 033120/0669 →
Continuity (2)
Provisional Application 61569008 · Dec 9, 2011
Related Publication 20140349344A1 · Nov 27, 2014